The Untapped Pharmacopeic Potential of Helminths
Authors:
- 1 October 2018
- journal article
- review article
- Published by Elsevier in Trends in Parasitology
- Vol. 34 (10) , 828-842
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trialTrials, 2013
- Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathwaysNature Medicine, 2012
- Safety and Immunogenicity of rSh28GST Antigen in Humans: Phase 1 Randomized Clinical Study of a Vaccine Candidate against Urinary SchistosomiasisPLOS Neglected Tropical Diseases, 2012
- Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitisClinical Immunology, 2012
- Exosome Secretion: Molecular Mechanisms and Roles in Immune ResponsesTraffic, 2011
- Effect of Hookworm Infection on Wheat Challenge in Celiac Disease – A Randomised Double-Blinded Placebo Controlled TrialPLOS ONE, 2011
- Parasitic Helminth Cystatin Inhibits DSS-Induced Intestinal Inflammation Via IL-10+F4/80+Macrophage RecruitmentThe Korean Journal of Parasitology, 2011
- The landscape of human genes involved in the immune response to parasitic wormsBMC Ecology and Evolution, 2010
- Experimental hookworm infection: a randomized placebo‐controlled trial in asthmaClinical & Experimental Allergy, 2010
- The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory diseaseClinical and Experimental Immunology, 2009